Liam Mulroy
Overview
Explore the profile of Liam Mulroy including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
1502
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Harrow S, Palma D, Olson R, Gaede S, Louie A, Haasbeek C, et al.
Int J Radiat Oncol Biol Phys
. 2022 Jun;
114(4):611-616.
PMID: 35643253
Purpose: Long-term randomized data assessing the effect of ablative therapies in patients with oligometastases are lacking. The Stereotactic Ablative Radiotherapy for the Comprehensive Treatment of Oligometastases (SABR-COMET) randomized phase 2...
2.
Louie A, Granton P, Fairchild A, Bezjak A, Gopaul D, Mulroy L, et al.
JAMA Oncol
. 2022 Feb;
8(4):1-7.
PMID: 35201290
Importance: Palliative thoracic radiotherapy (RT) can alleviate local symptoms associated with advanced non-small cell lung cancer (NSCLC), but esophagitis is a common treatment-related adverse event. Whether esophageal-sparing intensity-modulated RT (ES-IMRT)...
3.
Hebb A, Erjavec N, Morris D, Shoman N, Mulroy L, Walling S
Am J Otolaryngol
. 2020 Jun;
41(6):102559.
PMID: 32527669
Cerebellopontine angle (CPA) tumours account for 6-10% of intracranial tumours. The most common CPA tumours are vestibular schwannomas (VS), also known as acoustic neuromas, benign tumours of the vestibulocochlear nerve....
4.
Palma D, Olson R, Harrow S, Gaede S, Louie A, Haasbeek C, et al.
J Clin Oncol
. 2020 Jun;
38(25):2830-2838.
PMID: 32484754
Purpose: The oligometastatic paradigm hypothesizes that patients with a limited number of metastases may achieve long-term disease control, or even cure, if all sites of disease can be ablated. However,...
5.
Sengupta A, Wilke D, Cherpak A, Chytyk-Praznik K, Schella J, Yewondwossen M, et al.
Cureus
. 2020 Feb;
12(2):e6900.
PMID: 32064218
Total body irradiation (TBI) is used prior to bone marrow transplantation as part of the conditioning regimen in selected patients. A linear accelerator-based technique was used at our treatment centre...
6.
Olson R, Senan S, Harrow S, Gaede S, Louie A, Haasbeek C, et al.
Int J Radiat Oncol Biol Phys
. 2019 Aug;
105(5):943-947.
PMID: 31470091
Purpose: Randomized data assessing the longitudinal quality of life (QoL) impact of stereotactic ablative radiation therapy (SABR) in the oligometastatic setting are lacking. Methods And Materials: We enrolled patients who...
7.
Palma D, Olson R, Harrow S, Correa R, Schneiders F, Haasbeek C, et al.
BMC Cancer
. 2019 Aug;
19(1):816.
PMID: 31426760
Background: Stereotactic ablative radiotherapy (SABR) has emerged as a new treatment option for patients with oligometastatic disease. SABR delivers precise, high-dose, hypofractionated radiotherapy, and achieves excellent rates of local control...
8.
Davis C, Thomas C, Abdolell M, Day A, Hollenhorst H, Rajaraman M, et al.
J Med Imaging Radiat Sci
. 2019 May;
46(2):148-155.
PMID: 31052088
Introduction: The aim of this study was to quantify the impact of positron emission tomography-computed tomography (PET-CT) on clinical target volume (CTV) selection in non-small cell lung cancer (NSCLC) and...
9.
Palma D, Olson R, Harrow S, Gaede S, Louie A, Haasbeek C, et al.
Lancet
. 2019 Apr;
393(10185):2051-2058.
PMID: 30982687
Background: The oligometastatic paradigm suggests that some patients with a limited number of metastases might be cured if all lesions are eradicated. Evidence from randomised controlled trials to support this...
10.
Hebb A, Erjavec N, Morris D, Mulroy L, Bance M, Shoman N, et al.
Am J Otolaryngol
. 2018 Dec;
40(2):236-246.
PMID: 30554886
Patients with vestibular schwannomas (VS) typically present with hearing loss and tinnitus as well as variable cranial nerve dysfunctions. Surgical resection, stereotactic radiotherapy and/or conservative management employing serial magnetic resonance...